Login
| TI Ref No : | 526256668 |
|---|---|
| Description : | Gileads investigational single-tablet regimen of bictegravir and lenacapavir for hiv treatment meets primary endpoint in phase 3 artistry-2 trial |
| Date : | 2025-12-16 |
| Deadline : | 0000-00-00 |
| Document Type : | Procurement News |
